380 related articles for article (PubMed ID: 20022940)
41. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism.
Cebeci E; Alibaz-Oner F; Usta M; Yurdakul S; Erguney M
J Investig Med; 2012 Jan; 60(1):23-8. PubMed ID: 21997314
[TBL] [Abstract][Full Text] [Related]
43. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
44. Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.
Koncsos P; Seres I; Harangi M; Illyés I; Józsa L; Gönczi F; Bajnok L; Paragh G
Pediatr Res; 2010 Mar; 67(3):309-13. PubMed ID: 19915520
[TBL] [Abstract][Full Text] [Related]
45. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Schulpis KH; Barzeliotou A; Papadakis M; Rodolakis A; Antsaklis A; Papassotiriou I; Vlachos GD
Clin Biochem; 2008 Mar; 41(4-5):282-7. PubMed ID: 18035058
[TBL] [Abstract][Full Text] [Related]
46. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
[TBL] [Abstract][Full Text] [Related]
47. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
[TBL] [Abstract][Full Text] [Related]
48. Serum arylesterase and paraoxonase activities in patients with ovarian tumors.
Michalak S; Szubert S; Moszynski R; Sajdak S; Szpurek D
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):490-3. PubMed ID: 25510689
[TBL] [Abstract][Full Text] [Related]
49. Paraoxonase and arylesterase activities in coronary artery disease.
Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
[TBL] [Abstract][Full Text] [Related]
50. Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.
Cervellati C; Trentini A; Romani A; Bellini T; Bosi C; Ortolani B; Zurlo A; Passaro A; Seripa D; Zuliani G
J Neurochem; 2015 Oct; 135(2):395-401. PubMed ID: 26178739
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata.
Dizen-Namdar N; Emel Kocak F; Kidir M; Sarici G; Tak H; Altuntas I
Skin Pharmacol Physiol; 2019; 32(2):59-64. PubMed ID: 30544126
[TBL] [Abstract][Full Text] [Related]
52. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
53. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome.
Akçay AB; Camsarı A; Ozcan T; Ciçek D; Akkuş N; Seyis S; Cimen B; Celebi B; Döven O; Cin G
Turk Kardiyol Dern Ars; 2011 Jul; 39(5):371-7. PubMed ID: 21743260
[TBL] [Abstract][Full Text] [Related]
54. Oxidative stress in the adult and pediatric patients with Crimean-Congo haemorrhagic fever.
Aydin H; Guven FM; Yilmaz A; Engin A; Sari I; Bakir D
J Vector Borne Dis; 2013 Dec; 50(4):297-301. PubMed ID: 24499853
[TBL] [Abstract][Full Text] [Related]
55. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.
Cebeci E; Oner FA; Usta M; Yurdakul S; Erguney M
Acta Biomed; 2011 Dec; 82(3):214-22. PubMed ID: 22783718
[TBL] [Abstract][Full Text] [Related]
57. The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.
Dullaart RP; Kwakernaak AJ; Dallinga-Thie GM
Atherosclerosis; 2013 Sep; 230(1):6-11. PubMed ID: 23958245
[TBL] [Abstract][Full Text] [Related]
58. A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome.
Ebron K; Andersen CJ; Aguilar D; Blesso CN; Barona J; Dugan CE; Jones JL; Al-Sarraj T; Fernandez ML
Metab Syndr Relat Disord; 2015 Dec; 13(10):458-64. PubMed ID: 26431271
[TBL] [Abstract][Full Text] [Related]
59. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
Yang SP; Gong CX; Cao BY; Yan C
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
[TBL] [Abstract][Full Text] [Related]
60. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
